In June 2025, the FDA released a white paper emphasizing the need for stronger cybersecurity in medical product manufacturing, specifically focusing on Operational Technology (OT). The paper, titled “Securing Technology and Equipment (Operational Technology) Used for Medical Product Manufacturing,” highlights how increased connectivity in manufacturing environments can create vulnerabilities if cybersecurity isn’t prioritized. The FDA urges manufacturers to adopt state-of-the-art cybersecurity practices for OT to reduce the risk of cyber incidents and ensure the safety and reliability of medical products.
News & Trends
Procurar
Recentes
- A Formiventos está novamente no ranking das Top 5% melhores PME de Portugal
- Electronic Submission Template for Premarket Approval Applications (PMAs)
- MDSAP Technical Review and Recognition Decision Procedure
- Essential Principles and Content of Predetermined Change Control Plans. Final Document
- Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
- GMP and GDP Question and Answer Guide Version 03 published by ECA
- Guideline on good pharmacovigilance practices (GVP) Module III – Pharmacovigilance inspections (Rev 2)
- Publication of COMBINE Project 2 Sponsors’ guide on safety reporting in combined studies

